Formulation Index

  • Home
  • News
  • Year Wise
  • _2011
  • _2014
  • Oral Solid
  • _Tablet
  • _Capsules
  • _Powder
  • Semi Solid
  • Guidelines
  • _US FDA Guidelines
  • _ICH Guidelines

Dissolution Testing and Acceptance Criteria for Immediate-Release Solid Oral Dosage Form Drug Products Containing High Solubility Drug Substances

March 23, 2019 0 Comments

The US Food and Drug Administration (FDA) on Wednesday released final guidance for sponsors on when a standard release test and criteria may be used in…

Read more

CRIZOTINIB (XALKORI)

March 23, 2019 0 Comments

Crizotinib HDPE Bottle   Crizotinib capsules 200 mg   Crizotinib capsules 250 mg …

Read more
Older Posts

Report Abuse

Dissolution Testing and Acceptance Criteria for Immediate-Release Solid Oral Dosage Form Drug Products Containing High Solubility Drug Substances

March 23, 2019

Popular

Size, Shape, and Other Physical Attributes of Generic Tablets and Capsules

March 22, 2019

APREMILAST (OTEZLA)

March 22, 2019

Recents

[getWidget results='3' label='recent' type='list']

Comments

[getWidget results='3' label='comments' type='list']
Formulation Index

about-text

Formulation Index provides the most comprehensive information for Formulation R&D professionals. It is providing complete solution for formulation development. Formulation Index is providing support for R&D and Marketing professionals.


Email: info.formulationindex@gmail.com

Recent Posts

[getWidget results='2' label='recent' type='list']

Footer Menu

  • Home
  • About
  • Privacy
  • Contact Us
Design by Templateify Distributed by Weblyb

Contact Form